Christopher L. Haga

1.4k total citations
24 papers, 1.1k citations indexed

About

Christopher L. Haga is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Christopher L. Haga has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Christopher L. Haga's work include MicroRNA in disease regulation (7 papers), Mesenchymal stem cell research (6 papers) and RNA modifications and cancer (5 papers). Christopher L. Haga is often cited by papers focused on MicroRNA in disease regulation (7 papers), Mesenchymal stem cell research (6 papers) and RNA modifications and cancer (5 papers). Christopher L. Haga collaborates with scholars based in United States, Taiwan and Czechia. Christopher L. Haga's co-authors include Donald G. Phinney, Sai Pradeep Velagapudi, Matthew D. Disney, Max D. Cooper, Sajni Josson, Murali Gururajan, Siddaraju V. Boregowda, Jessica L. Childs‐Disney, Randall S. Davis and Götz R. A. Ehrhardt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Christopher L. Haga

21 papers receiving 1.1k citations

Peers

Christopher L. Haga
Yolanda Campos‐Martín Spain
Vida Vafaizadeh Germany
Mumtaz V. Rojiani United States
Delphine Ciais France
Barbara Zagatti Italy
Kai P. Hoefig Germany
Shulian Shang United States
Jiří Šáňa Czechia
Robert W. Georgantas United States
Jlenia Guarnerio United States
Yolanda Campos‐Martín Spain
Christopher L. Haga
Citations per year, relative to Christopher L. Haga Christopher L. Haga (= 1×) peers Yolanda Campos‐Martín

Countries citing papers authored by Christopher L. Haga

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Haga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Haga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Haga more than expected).

Fields of papers citing papers by Christopher L. Haga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Haga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Haga. The network helps show where Christopher L. Haga may publish in the future.

Co-authorship network of co-authors of Christopher L. Haga

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Haga. A scholar is included among the top collaborators of Christopher L. Haga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Haga. Christopher L. Haga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haga, Christopher L., Chap T. Le, Xue Yang, & Donald G. Phinney. (2025). Py-CoMSIA: An Open-Source Implementation of Comparative Molecular Similarity Indices Analysis in Python. Pharmaceuticals. 18(3). 440–440.
2.
Yang, Xue, Christopher L. Haga, & Donald G. Phinney. (2025). Signaling Dynamics in Osteogenesis: Unraveling Therapeutic Targets for Bone Generation. Current Drug Targets. 26(5). 350–366.
3.
Haga, Christopher L., et al.. (2024). Comparative transcriptome analysis of bone marrow resident versus culture-expanded mouse mesenchymal stem/stromal cells. Cytotherapy. 26(5). 498–505. 3 indexed citations
4.
Haga, Christopher L., Cori N. Booker, Ana Luı́sa Carvalho, Siddaraju V. Boregowda, & Donald G. Phinney. (2023). Transcriptional Targets of TWIST1 in Human Mesenchymal Stem/Stromal Cells Mechanistically Link Stem/Progenitor and Paracrine Functions. Stem Cells. 41(12). 1185–1200. 4 indexed citations
5.
Boregowda, Siddaraju V., et al.. (2023). Novel role for alpha-2-macroglobulin (A2M) as a disease modifying protein in senile osteoporosis. Frontiers in Cell and Developmental Biology. 11.
6.
Haga, Christopher L., et al.. (2023). Graph neural networks for the identification of novel inhibitors of a small RNA. SLAS DISCOVERY. 28(8). 402–409. 2 indexed citations
7.
Lee, Ryang Hwa, Siddaraju V. Boregowda, Eun‐Hye Bae, et al.. (2023). TWIST1 and TSG6 are coordinately regulated and function as potency biomarkers in human MSCs. Science Advances. 9(45). eadi2387–eadi2387. 7 indexed citations
8.
9.
Ballow, Mark & Christopher L. Haga. (2021). Why Do Some People Develop Serious COVID-19 Disease After Infection, While Others Only Exhibit Mild Symptoms?. The Journal of Allergy and Clinical Immunology In Practice. 9(4). 1442–1448. 16 indexed citations
10.
11.
Boregowda, Siddaraju V., et al.. (2018). Basal p53 expression is indispensable for mesenchymal stem cell integrity. Cell Death and Differentiation. 25(4). 679–692. 41 indexed citations
12.
Costales, Matthew G., Christopher L. Haga, Sai Pradeep Velagapudi, et al.. (2017). Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit. Journal of the American Chemical Society. 139(9). 3446–3455. 133 indexed citations
13.
Haga, Christopher L., et al.. (2016). Rapid Generation of miRNA Inhibitor Leads by Bioinformatics and Efficient High-Throughput Screening Methods. Methods in molecular biology. 1517. 179–198. 14 indexed citations
14.
Boregowda, Siddaraju V., Veena Krishnappa, Christopher L. Haga, Luis A. Ortiz, & Donald G. Phinney. (2015). A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells. EBioMedicine. 4. 62–73. 74 indexed citations
15.
Gururajan, Murali, Sajni Josson, Gina Chia‐Yi Chu, et al.. (2014). miR-154* and miR-379 in the DLK1-DIO3 MicroRNA Mega-Cluster Regulate Epithelial to Mesenchymal Transition and Bone Metastasis of Prostate Cancer. Clinical Cancer Research. 20(24). 6559–6569. 82 indexed citations
16.
Josson, Sajni, Murali Gururajan, Shian‐Ying Sung, et al.. (2014). Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene. 34(21). 2690–2699. 170 indexed citations
17.
Haga, Christopher L. & Donald G. Phinney. (2012). MicroRNAs in the Imprinted DLK1-DIO3 Region Repress the Epithelial-to-Mesenchymal Transition by Targeting the TWIST1 Protein Signaling Network. Journal of Biological Chemistry. 287(51). 42695–42707. 102 indexed citations
18.
Gururajan, Murali, Christopher L. Haga, Sabyasachi Das, et al.. (2010). MicroRNA 125b inhibition of B cell differentiation in germinal centers. International Immunology. 22(7). 583–592. 129 indexed citations
19.
Haga, Christopher L., et al.. (2010). FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells. The Journal of Immunology. 185(12). 7405–7412. 43 indexed citations
20.
Haga, Christopher L., et al.. (2007). A conserved gene family encodes transmembrane proteins with fibronectin, immunoglobulin and leucine-rich repeat domains (FIGLER). BMC Biology. 5(1). 36–36. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yolanda Campos‐Martín Breakdown of academic impact, for papers by Vida Vafaizadeh Breakdown of academic impact, for papers by Mumtaz V. Rojiani Breakdown of academic impact, for papers by Delphine Ciais Breakdown of academic impact, for papers by Barbara Zagatti Breakdown of academic impact, for papers by Kai P. Hoefig Breakdown of academic impact, for papers by Shulian Shang Breakdown of academic impact, for papers by Jiří Šáňa Breakdown of academic impact, for papers by Robert W. Georgantas Breakdown of academic impact, for papers by Jlenia Guarnerio
Rankless by CCL
2026